title: A mixed-type autoimmune hemolytic anemia with immune thrombocytopenia related with myositis and post-transplantation lymphoproliferative disorder.
authors.affiliation: Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
authors.forename: Mizuki
authors.initials: M
authors.lastname: Ogura
authors.forename: Motoshi
authors.initials: M
authors.lastname: Ichikawa
authors.forename: Akiko
authors.initials: A
authors.lastname: Masuda
authors.forename: Koji
authors.initials: K
authors.lastname: Kandabashi
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Nannya
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000473:pathology* / Q000628:therapy; D006086:Graft vs Host Disease / Q000150:complications / Q000473:pathology* / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000473:pathology* / Q000628:therapy; D008297:Male; D019653:Myeloablative Agonists / Q000627:therapeutic use; D009220:Myositis / Q000150:complications / Q000473:pathology* / Q000628:therapy; D013921:Thrombocytopenia / Q000150:complications / Q000473:pathology* / Q000628:therapy; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous
chemical_list: D019653:Myeloablative Agonists